COLUMBIA, Md., May 22 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced that it intends to release the results of its second quarter of fiscal 2008 on June 4, 2008, at approximately 4:00 p.m. Eastern Time (ET). Following the release, at 4:45 p.m. ET Martek will conduct a conference call to discuss the results of its second quarter of fiscal 2008 with investors. All interested parties may listen to the call live via webcast by visiting Martek’s Web site at http://investors.martek.com .
An archived webcast of the conference call will be available on the Martek’s website for 30 days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 or 402-977-9140 and entering pass code 213 835 69.
Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life’sDHA(TM), a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula and supplements, and life’sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/ .
CONTACT: Kyle Stults, Investor Relations, or Cassie France-Kelly, Public
Relations, both of Martek Biosciences Corporation, +1-410-740-0081
Web site: http://www.martek.com/
http://investors.martek.com/
